HomeNPCE • NASDAQ
Follow
Neuropace Inc
Previous close
$14.04
Day range
$13.53 - $14.19
Year range
$3.80 - $18.15
Market cap
389.74M USD
Avg Volume
136.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 18.01M | 40.84% |
Operating expense | 18.60M | -0.35% |
Net income | -6.20M | 44.37% |
Net profit margin | -34.42 | 60.50% |
Earnings per share | -0.23 | 48.89% |
EBITDA | -5.01M | 48.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 66.45M | -14.15% |
Total assets | 107.65M | -5.66% |
Total liabilities | 87.00M | 9.67% |
Total equity | 20.65M | — |
Shares outstanding | 28.34M | — |
Price to book | 18.97 | — |
Return on assets | -12.20% | — |
Return on capital | -13.94% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -6.20M | 44.37% |
Cash from operations | -3.34M | 57.40% |
Cash from investing | 3.47M | -61.02% |
Cash from financing | 8.21M | 6,052.17% |
Net change in cash | 8.34M | 809.60% |
Free cash flow | -2.02M | 60.26% |
About
Founded
1997
Website
Employees
171